back to explore
Xeris Biopharma Holdings, Inc. logo

XERS

Xeris Biopharma Holdings, Inc.
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2018-06-21
$10.35
+0.18 (+1.77%)
last quote
Want the full multi-source brief on XERS?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$10.35
High
$10.56
Low
$10.17
Previous close
$10.17
Fundamentals
Market cap
$1.90B
P/E (TTM)
—
P/S (TTM)
5.67x
P/B
97.76x
Gross margin
86.58%
Operating margin
1.73%
Net margin
-5.12%
Rev growth (YoY)
36.33%
EPS growth (YoY)
—
ROE
99.74%
52W high
$11.41
52W low
$5.25
Beta
0.77x
Upcoming earnings
next 30 days
2026-11-05todaybefore market
Q3 2026EPS est $0.02Rev est $103.5M
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial